Thixotropic property in pharmaceutical formulations

被引:299
|
作者
Lee, Chi H. [1 ]
Moturi, Venkat [1 ]
Lee, Yugyung [2 ]
机构
[1] Univ Missouri, Div Pharmaceut Sci, Sch Pharm, Kansas City, MO 64110 USA
[2] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64110 USA
关键词
Viscosity; Thixotropic property; The influencing factors; Pharmaceutical applications; GELLING XYLOGLUCAN FORMULATIONS; IN-VITRO; RHEOLOGICAL BEHAVIOR; NASAL SPRAYS; GELS; RELEASE; DELIVERY; SYSTEMS; HYDROGELS; VEHICLES;
D O I
10.1016/j.jconrel.2009.02.013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This review focuses on the characterization of the thixotropic property, the factors affecting the thixotropic property and its pharmaceutical applications. These factors include pH, temperature, polymer concentrations, polymer modification, polymer combinations, and addition of cations or excipients. The relationships between the rheological properties of thixotropic formulations, and their effects on the controlled drug delivery through various routes including oral, topical, ophthalmic, dental and mucosal administration and pharmacological efficacies were also discussed. The comprehensive analysis of theological and mechanical properties will provide an insight into the potential usage of thixotropic formulations as drug delivery systems. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:88 / 98
页数:11
相关论文
共 50 条
  • [1] THE FILLING OF MOLTEN AND THIXOTROPIC FORMULATIONS INTO HARD GELATIN CAPSULES
    WALKER, SE
    GANLEY, JA
    BEDFORD, K
    EAVES, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (06) : 389 - 393
  • [2] PHARMACEUTICAL FORMULATIONS OF ANTHRALIN
    WHITEFIELD, M
    BRITISH JOURNAL OF DERMATOLOGY, 1981, 105 : 28 - 32
  • [3] Hydrolysis in pharmaceutical formulations
    Waterman, KC
    Adami, RC
    Alsante, KM
    Antipas, AS
    Arenson, DR
    Carrier, R
    Hong, JY
    Landis, MS
    Lombardo, F
    Shah, JC
    Shalaev, E
    Smith, SW
    Wang, H
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2002, 7 (02) : 113 - 146
  • [4] VITAMINS IN PHARMACEUTICAL FORMULATIONS
    DERITTER, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (10) : 1073 - 1096
  • [5] Hydrogels in pharmaceutical formulations
    Peppas, NA
    Bures, P
    Leobandung, W
    Ichikawa, H
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 27 - 46
  • [6] Tensorial formulations for improved thixotropic viscoelastic modeling of human blood
    Armstrong, Matthew
    Pincot, Andre
    Jariwala, Soham
    Horner, Jeff
    Wagner, Norman
    Beris, Antony
    JOURNAL OF RHEOLOGY, 2022, 66 (02) : 327 - 347
  • [7] Pharmaceutical excipients and pediatric formulations
    Yochana, Srivari
    Yu, Meiki
    Alvi, Mohammed
    Varenya, Sri
    Chatterjee, Parnali
    CHIMICA OGGI-CHEMISTRY TODAY, 2012, 30 (05) : 56 - 61
  • [8] Pharmaceutical Peptide Formulations.
    Birr, P. E.
    Buckel, B.
    Kuenzel, S.
    Birr, Christian
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 179 - 180
  • [9] Determination of Mizolastine in pharmaceutical formulations
    Sreelakshmi, A.
    Rao, G. Devala
    Babu, G. Sudhakara Sai
    ORIENTAL JOURNAL OF CHEMISTRY, 2010, 26 (01) : 239 - 242
  • [10] Determination of carbamazepine in pharmaceutical formulations
    da Silva Solon, Lilian Grace
    Maia de Oliveira, Ana Isabel
    Bernardo Guerra, Gerlane Coelho
    Lira Soares, Luiz Alberto
    de Araujo, Aurigena Antunes
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (03) : 509 - 513